IIM
Clinical trials for IIM explained in plain language.
Never miss a new study
Get alerted when new IIM trials appear
Sign up with your email to follow new studies for IIM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at lupus and MS
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, which uses a patient's own immune cells modified to target and calm overactive immune cells in autoimmune diseases. The trial includes 18 adults with conditions like lupus, systemic sclerosis, multiple sclerosis, and ot…
Matched conditions: IIM
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Immune cell combo tackles tough autoimmune conditions
Disease control Recruiting nowThis study tests a new treatment for people with certain autoimmune diseases (rheumatoid arthritis, Sjögren's disease, myositis, and scleroderma) that have not responded to standard therapies. The treatment combines AlloNK, a type of immune cell from donated cord blood, with ritu…
Matched conditions: IIM
Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Universal CAR-T therapy aims to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, which uses specially engineered immune cells to target and calm overactive immune responses in people with autoimmune diseases like lupus, vasculitis, and scleroderma. Up to 84 adults aged 18 to 75 will receive the ther…
Matched conditions: IIM
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Patients take the lead: rare disease research gets a new voice
Knowledge-focused Recruiting nowThis study asks people living with rare myositis diseases (and their caregivers) what research questions matter most to them. Researchers will collect ideas through online surveys and forums. The goal is to create a patient-driven list of priorities to guide future studies and fu…
Matched conditions: IIM
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC